Concepedia

Author

Kazuko Nagase

Hyogo Medical UniversityORCID

Also Known As

K Nagase, K. Nagase, Kazuko Nagase, Kouji NAGASE, Nagase K

62

Publications

1.2K

Citations

17

H-Index

45

Concepts

All Affiliations

Hyogo Medical UniversityMochida Pharmaceutical (Japan)Mie University
KN

About

Kazuko Nagase is an author at Hyogo Medical University specializing in medicine, autoimmunity, and autoimmune disease.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

9

9

513

2

Health Sciences

3

3

205

3

Biochemistry

3

3

304

4

Allergy

2

2

55

5

Cell Biology

1

1

69

Kazuko Nagase

×

19

Publications

1.1K

Citations

17

H-Index

YearCitations

Scheduled infliximab monotherapy to prevent recurrence of Crohnʼs disease following ileocolic or ileal resection: A 3-year prospective randomized open trial

Kōji Yoshida, Ken Fukunaga, Hiroki Ikeuchi,

Inflammatory Bowel Diseases

2011

151

Metabolism of FK506, a potent immunosuppressive agent, by cytochrome P450 3A enzymes in rat, dog and human liver microsomes

Toshipumi Shiraga, Hiroji Matsuda, Kazuko Nagase,

Biochemical Pharmacology

1994

130

Distribution and Protein Binding of FK506, a Potent Immunosuppressive Macrolide Lactone, in Human Blood and Its Uptake by Erythrocytes

Kazuko Nagase, Kazuhide Iwasaki, Katsuko Nozaki,

Journal of Pharmacy and Pharmacology

1994

115

Isolation, identification, and biological activities of oxidative metabolites of FK506, a potent immunosuppressive macrolide lactone.

Kenji Iwasaki, Toshifumi Shiraga, Kazuko Nagase,

Drug Metabolism and Disposition

1993

106

Further metabolism of FK506 (tacrolimus). Identification and biological activities of the metabolites oxidized at multiple sites of FK506.

Kenji Iwasaki, Toshifumi Shiraga, H Matsuda,

Drug Metabolism and Disposition

1995

104

Distribution and protein binding of FK506, a potent immunosuppressive macrolide latone, in human blood and its uptake by erythrocytes

Kazuko Nagase

Medical Entomology and Zoology

1994

69

Effects of twenty-three drugs on the metabolism of FK506 by human liver microsomes.

Kenji Iwasaki, H Matsuda, Kazuko Nagase,

PubMed

1993

59

Placebo controlled evaluation of Xilei San, a herbal preparation in patients with intractable ulcerative proctitis

Ken Fukunaga, Yoshio Ohda, Nobuyuki Hida,

Journal of Gastroenterology and Hepatology

2012

41

The expression profile of functional regulatory T cells, CD4+CD25high+/forkhead box protein P3+, in patients with ulcerative colitis during active and quiescent disease

Koji Kamikozuru, Ken Fukunaga, Shigeru Hirota,

Clinical & Experimental Immunology

2009

41

Complications of Leukocytapheresis

Kazuko Nagase, Koji Sawada, Kunio Ohnishi,

Therapeutic Apheresis

1998

39

Page 1